Associated Papers
The Distinct Roles of LKB1 and AMPK in p53-Dependent Apoptosis Induced by Cisplatin.
Shimada T et al.
International Journal of Molecular Sciences, 2022
Corrigendum to "Re-expression of LKB1 in LKB1-mutant EKVX cells leads to resistance to paclitaxel through the up-regulation of MDR1 expression" [Lung Cancer 88/2 (2015) 131-138].
Mao K et al.
Lung Cancer (amsterdam, Netherlands), 2021
Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 status.
Zhang J et al.
Oncotarget, 2017
Fyn-phosphorylated PIKE-A binds and inhibits AMPK signaling, blocking its tumor suppressive activity.
Zhang S et al.
Cell Death and Differentiation, 2016
LKB1 controls human bronchial epithelial morphogenesis through p114RhoGEF-dependent RhoA activation.
Xu X et al.
Molecular and Cellular Biology, 2013
STE20-related kinase adaptor protein α (STRADα) regulates cell polarity and invasion through PAK1 signaling in LKB1-null cells.
Eggers CM et al.
The Journal of Biological Chemistry, 2012
Genome-wide RNAi screen reveals disease-associated genes that are common to Hedgehog and Wnt signaling.
Jacob LS et al.
Science Signaling, 2011
Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC).
Kim DW et al.
Molecular Endocrinology (baltimore, Md.), 2007
LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation.
Zeng PY et al.
Cancer Research, 2006
The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death.
Karuman P et al.
Molecular Cell, 2001
An LKB1-interacting protein negatively regulates TNFalpha-induced NF-kappaB activation.
Liu WK et al.
Journal of Biomedical Science, 0
Select a paper to view details